ELIZABETH STAPPER: Open Payments
NPI 1427708981 · SHENANDOAH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,015 in 134 payments from 17 companies in 2025. Trend: 2023 $2,186 · 2024 $2,925 · 2025 $3,015
Food & beverage: $2,915Education: $100
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 19 | $520 |
| Janssen Biotech, Inc. | 14 | $454 |
| Amgen Inc. | 23 | $454 |
| AstraZeneca Pharmaceuticals LP | 14 | $431 |
| ABBVIE INC. | 22 | $386 |
| Novartis Pharmaceuticals Corporation | 14 | $213 |
| Radius Health, Inc. | 7 | $144 |
| GlaxoSmithKline, LLC. | 7 | $123 |
| E.R. Squibb & Sons, L.L.C. | 5 | $87 |
| ANI Pharmaceuticals, Inc. | 2 | $49 |
Products named: Bimzelx, TREMFYA, SAPHNELO, ENBREL, RINVOQ, COSENTYX, SKYRIZI, Tymlos.
Industry payments across TX — which companies pay providers there.
